IA
LENZ

IFP Advisors’s LENZ Therapeutics LENZ Stock Holding History

IFP Advisors’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23K Buy
392
+375
+2,206% +$3.02K ﹤0.01% 4190
2026
Q1 		$156 Buy
+17
New +$239 ﹤0.01% 4662
2025
Q2 		– Hold
0
– – – 4654
2024
Q4 		– Hold
0
– – – 4392

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

IFP Advisors's LENZ Position: Q2 2026 in Review

IFP Advisors increased its LENZ Therapeutics (LENZ) stake by 2,206% in Q2 2026, buying an estimated $3.02K and bringing the position to 392 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #4190.

IFP Advisors first reported a position in LENZ in Q1 2026 and has held it in 2 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • IFP Advisors held 392 shares of LENZ Therapeutics worth $2.23K as of Q2 2026.
  • IFP Advisors bought 375 LENZ Therapeutics shares in Q2 2026, an estimated $3.02K.
  • LENZ Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4190 holding.
  • IFP Advisors first reported a position in LENZ Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.